HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity ECG platform designed […]

Innovation-focused names are setting the tone this morning, with capital flows clustering around companies showing clear execution milestones, commercial inflection points, and technical breakouts.

Dubai, UAE, February 13th, 2026, FinanceWire

Ebene, Mauritius, February 13th, 2026, FinanceWire